Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 31 December 2009 and unaudited. Performance at month end with net income reinvested One Three One Three Since Launch Month Months Year Years (20 Sep 04) Net asset value 3.0% 0.2% 25.8% 9.4% 93.3% Share price 3.6% 2.7% 28.4% 10.4% 86.8% FTSE World Europe ex UK 2.6% 0.6% 20.1% 9.9% 74.5% Sources: BlackRock and Datastream At month end Net asset value (capital only): 178.49p Net asset value (including income): 178.59p* * Includes net revenue of 0.10p Share price: 172.25p Discount to NAV (capital only): 3.5% Discount to NAV (including income): 3.6% Gearing (including income): 2.4% Net yield: 1.8% Total assets (including income): £186.0m Ordinary shares in issue: 101,684,469** ** Excluding 3,440,129 shares held in treasury. Sector Analysis Total Assets Index (%) Country Analysis Total Assets (%) (%) Industrials 20.8 12.8 Switzerland 26.4 Financials 20.5 25.7 France 18.5 Consumer Goods 12.0 14.6 Germany 12.6 Health Care 11.0 8.9 Netherlands 7.3 Consumer Services 7.9 5.0 Spain 6.3 Oil & Gas 6.4 7.4 Finland 5.0 Basic Materials 6.1 7.5 Belgium 4.0 Telecommunications 5.9 7.0 Portugal 3.7 Utilities 5.1 7.7 Sweden 2.5 Technology 4.2 3.4 Austria 2.4 Net current assets 0.1 - Russia 2.4 ----- ----- Greece 2.1 100.0 100.0 Hungary 1.3 ===== ===== Norway 1.0 Luxembourg 1.0 Poland 0.9 Czech Republic 0.9 Bermuda 0.9 Ireland 0.7 Net current assets 0.1 ----- 100.0 ===== Ten Largest Equity Investments (in alphabetical order) Company Country of Risk Anheuser-Busch Belgium Bayer Germany BNP Paribas France ING Netherlands Kuehne + Nagel Switzerland Nestlé Switzerland Novartis Switzerland Roche Switzerland Teliasonera Sweden Total France Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: Fund Performance & Attribution During the month, both the Company's NAV and share price outperformed the reference index. The NAV gained 3.0% (net) in Sterling terms and the share price gained 3.6% in the month. By contrast, the FTSE World Europe ex UK Index (net) returned 2.6%. Equity markets continued to be buffeted by news flow in the month. Greece's downgrade to BBB+, with negative outlook from Fitch the credit rating agency followed by the Basel Committee's consultation paper outlining more stringent capital requirements for banks, weighed heavily on the Financials sector. While Financials lagged the market, more economically sensitive sectors performed strongly as the outlook for the global economy and industrial activity continued to improve. Beneficiaries included the Materials, Industrials and Energy sectors. Within more defensive and consumer related areas, the Health Care and Consumer Goods sectors outperformed. Telecoms and Technology lagged the market in the month. In this context, the Company's relative performance was largely generated by positive stock selection. Positions in Health Care, Industrials and Telecommunications performed particularly well. The Company crystallised healthy profits in medical devices company Nobel Biocare towards the end of the month as the stock rallied, and a position in Dutch semiconductor equipment manufacturer ASML benefited from the confirmation of a strong outlook for its fourth quarter earnings. A position in Swiss recruitment firm Adecco benefited from improving employment data. We expect payrolls to turn positive in the first quarter of this year, which would provide a strong backdrop for improving company revenues. The Company's underweight position to Financials, relative to the reference index, delivered a positive contribution, although a holding in Greek bank EFG Eurobank detracted as investors avoided Greek banks on the back of continuing concerns for the Greek fiscal deficit. Positioning Relative to the reference index, the Company begins January overweight Consumer Discretionary, Industrials, Energy and Consumer Staples and underweight Utilities, Telecommunications, Materials and Financials. Outlook Against a backdrop of recovering earnings, well contained inflation and continued government stimulus tailwinds, we are positive on the outlook for European Equity markets in 2010. However, one of the key issues will be the outlook for policy stimulus and the extent to which private sector demand can replace it. It is our view that central banks will remain supportive while adopting a wait and see approach, looking for further economic recovery and stabilisation in unemployment before applying higher interest rates. At the corporate level, the ability of managements to position their company into the upturn will become increasingly important in determining future winners and losers. This will be especially important in 2010 as many companies look to benefit from strong cost discipline in the downturn. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 21 January 2010
UK 100

Latest directors dealings